• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.13% Nasdaq Up0.70%

    Acasti Pharma Inc. (ACST)

    -NasdaqCM
    0.54 Down 0.02(2.93%) Dec 26, 4:00PM EST
    Add to Portfolio
    ProfileGet Profile for:
    Acasti Pharma Inc.
    545 Promenade du Centropolis
    Suite 100
    Laval, QC H7T 0A3
    Canada - Map
    Phone: 450-686-4555
    Fax: 450-686-2505
    Website: http://www.acastipharma.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Biotechnology
    Full Time Employees:N/A

    Business Summary 

    Acasti Pharma Inc., a biopharmaceutical company, is engaged in the research, development, and commercialization of therapies for abnormalities in blood lipids, and the treatment and prevention of various cardiometabolic disorders in Canada and the United States. The company offers Onemia, a medical food that is used in the dietary management of illnesses associated with omega-3 phospholipids deficiency related to cardiometabolic disorders. Its product development pipeline includes CaPre, a drug product candidate that is in Phase II clinical trials for the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada. Acasti Pharma Inc. is a subsidiary of Neptune Technologies & Bioressources Inc.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Acasti Pharma Inc.

    Key Executives 
     PayExercised
    Mr. Pierre Lemieux Ph.D., M.D.,
    Chief Operating Officer
    148.00K0.00
    Dr. Fotini Sampalis M.D., Ph.D., 51
    Chief Global Strategic Officer
    48.00K0.00
    Mr. Andre Godin CPA, CA, 50
    Interim Chief Exec. Officer, Interim Pres and Interim Chief Financial Officer
    N/AN/A
    Mr. John Ripplinger ,
    Director of Investor Relations
    N/AN/A
    Dr. Bruno Battistini B.Sc., M.Sc., Ph.D.,
    Sr. Director of Pharmaceutical R&D
    N/AN/A
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders